[Ablative therapy in kidney cancer: Indications]

Ablative therapies (AT) in kidney cancer are rising. It's important to evaluate the situation of this therapy. The aim of this study is to identify the best indications for AT treatment for kidney cancer.

Review of literature using Medline and Embase databases. Study were selected based on scientific relevance. Clinical keys centered on the best requirements to indicate ablative therapies.

AT is indicated according to specific tumor and patients criteria. A good initial evaluation is essential (imaging, pathology, renal function and general condition of the patient). AT gets the best results when applied to the following tumor criteria: solid tumor, length<3cm, exophytic localization, RENAL score<8. In few cases, AT could be discussed as an alternative to the reference treatment, sparing surgery: life expectancy evaluated between 3 and 7 years, chronic renal failure or single kidney, transplanted kidney, familial tumors. AT can be used in first line, post-surgery after local recurrence or for distant metastasis. Like every other innovative technic, indications of AT would be adjust with learning curve and cost-effectiveness.

AT have to be included as a valid treatment for kidney cancer<4cm. The respect of actual indications and collection of results of AT compared to surveillance and surgery, would determinate the evolution of AT indications in the future.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2017 Aug 28 [Epub ahead of print]

T Tricard, G Tsoumakidou, V Lindner, J Garnon, G Albrand, X Cathelineau, A Gangi, H Lang

Service de chirurgie urologique, CHU de Strasbourg, 1, place de l'Hôpital, 67000 Strasbourg, France. Electronic address: ., Service d'imagerie interventionnelle, CHU de Strasbourg, 1 place de l'Hôpital, 67000 Strasbourg, France., Département de pathologie, CHU de Strasbourg, 1 place de l'Hôpital, 67000 Strasbourg, France., Service de gériatrie, hôpital Antoine-Charial, groupement hospitalier Sud des hospices civils de Lyon, 69340 Francheville, France., Département d'urologique, institut Montsouris, 75013 Paris, France; Université Paris-Descartes, 75006 Paris, France., Service de chirurgie urologique, CHU de Strasbourg, 1, place de l'Hôpital, 67000 Strasbourg, France.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe